The latest from Indica Labs: Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy. These precisely...

Join Leica Biosystems and NEO Genomics for next week's webinar. Optimization of IHC & digital pathology workflows in the development of novel therapeutic ADCs Date: March 5, 2025 Time: 8:00 AM (PT), 11:00 AM (ET) REGISTER...